Ulcerative colitis (UC) is a chronic, immune-mediated inflammatory disorder of the colon that follows a relapsing-remitting ...
In patients with ulcerative colitis, initiation of biologic therapy within 12 months of diagnosis is linked to a lower risk ...
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative ...
Everyday Health on MSN
How to manage a career and family during an ulcerative colitis treatment switch
Switching UC treatments while managing a career and home life can be a major challenge. Here’s how to navigate work logistics ...
New ECCO dietary therapy guidelines for IBD clarify the role of enteral nutrition, Mediterranean diet, supplements, and RD ...
T he goal of ulcerative colitis (UC) treatment is twofold: to heal the inflamed mucosal lining of the gut and to eliminate symptoms such as cramping and pain (usually once the inflammation subsides).
Pivotal Phase 3 global KEPLER study of vedolizumab intravenous (IV) in pediatric patients ages 2 to 17, who had an inadequate response to either conventional treatment options or tumor necrosis factor ...
The Department of Defense is tapping a research team led by Mount Sinai to study a novel treatment for ulcerative colitis, an enemy within that disproportionately impacts individuals in the military.
SHANGHAI, Feb. 6, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results